Hangzhou Minsheng Healthcare Co (SZSE:301507) EBIT per Share : ¥0.31 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co EBIT per Share?

Hangzhou Minsheng Healthcare Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.20. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.31.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Hangzhou Minsheng Healthcare Co's EBIT per Share or its related term are showing as below:

SZSE:301507's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Hangzhou Minsheng Healthcare Co's EBIT for the three months ended in Mar. 2024 was ¥68.4 Mil.

Hangzhou Minsheng Healthcare Co EBIT per Share Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co EBIT per Share Chart

Hangzhou Minsheng Healthcare Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.31

0.34

0.33

Hangzhou Minsheng Healthcare Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial									0.24	0.06	0.04	0.01	0.20

Hangzhou Minsheng Healthcare Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Hangzhou Minsheng Healthcare Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	96.905	/	295.289
=	0.33

Hangzhou Minsheng Healthcare Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	68.368	/	346.307
=	0.20

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.31

Hangzhou Minsheng Healthcare Co (SZSE:301507) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Hangzhou Minsheng Healthcare Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Minsheng Healthcare Co (SZSE:301507) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100

Website

http://www.21vita.com

Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co (SZSE:301507) Headlines

No Headlines